A 5-Week, Randomized, Double-Blind, Placebo-Controlled, Multi-Dose Safety, Tolerance & Pharmacokinetics Study of CI-1034 in Patients with Secondary Pulmonary Hypertension Associated with Cardiopumnary Disease

  • ABRAHAM, WILLIAM (PI)
  • LAMBA, SUMANT (CoI)

Grants and Contracts Details

StatusFinished
Effective start/end date6/15/0110/3/02